- socially bharat
- December 27, 2024
Netrack’s Innovative Solutions at BICSI Mumbai Gained Promising Audience Response
Bengaluru, Karnataka, India As we approached the last lap of this year, Netrack participated in the BICSI event in Mumbai. Being the
READ MORE
- socially bharat
- November 6, 2024
First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma
Oslo, Norway, November 6, 2024 – Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer
- socially bharat
- November 1, 2024
Biosergen Completes First Cohort of BSG005 Clinical Trial, Shows Promising Potential in Drug-Resistant Fungal Infections
October 31, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, today announced the
- socially bharat
- October 4, 2024
ProTrans highlighted as a promising treatment for type 1 diabetes in Dagens Medicin
NextCell Pharma AB* is proud that their drug candidate ProTrans has been highlighted in Dagens Medicin’s latest edition featuring ongoing research
- socially bharat
- October 4, 2024
The Global Most Promising Cross-Border Payments Companies for 2024
● Today, FXC Intelligence published the Global Most Promising Cross-Border Payments Companies for 2024. ● Now in its second year,
- socially bharat
- October 3, 2024
Saniona’s CEO to BioStock: “SAN2355 is a highly promising candidate for commercialization”
Thu, Oct 03, 2024 09:45 CET Report this content Saniona has announced significant progress in the preclinical development
- socially bharat
- September 13, 2024
Arka Launches its Second Fund of Rs. 500 Cr, with Rohan Builders as Operating Partner, to Foray into Promising Residential Equity Market
Arka Investment Advisory Services Private Limited (AIASPL) has launched their second alternative investment fund – Arka Hreem Real Estate Opportunities Fund (“Fund”). Rohan Builders,